{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:47:54Z","timestamp":1792788474652,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T00:00:00Z","timestamp":1745107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Taishan Scholars Foundation of Shandong Province","award":["NO.ts20190991"],"award-info":[{"award-number":["NO.ts20190991"]}]},{"name":"the Science and Technology Project of Medicine and Health Care in Shandong Province","award":["202304081359"],"award-info":[{"award-number":["202304081359"]}]},{"name":"Key R&D Project of Shandong Province","award":["2022CXPT023"],"award-info":[{"award-number":["2022CXPT023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1245\/s10434-025-17290-0","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T11:42:22Z","timestamp":1745149342000},"page":"4780-4789","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Deep Learning Survival Model for Evaluating the Survival Prognosis of Papillary Thyroid Cancer: A Population-Based Cohort Study"],"prefix":"10.1245","volume":"32","author":[{"given":"Guibin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinna","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zafereo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xicheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,20]]},"reference":[{"issue":"13","key":"17290_CR1","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jama.2017.2719","volume":"317","author":"H Lim","year":"2017","unstructured":"Lim H, Devesa SS, Sosa JA, et al. Trends in thyroid cancer incidence and mortality in the United States, 1974\u20132013. JAMA. 2017;317(13):1338\u201348.","journal-title":"JAMA."},{"issue":"11","key":"17290_CR2","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1089\/thy.2016.0100","volume":"26","author":"JJ Wiltshire","year":"2016","unstructured":"Wiltshire JJ, Drake TM, Uttley L, et al. Systematic review of trends in the incidence rates of thyroid cancer. Thyroid. 2016;26(11):1541\u201352.","journal-title":"Thyroid."},{"issue":"2","key":"17290_CR3","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1001\/jamaoto.2017.2416","volume":"144","author":"M Amit","year":"2018","unstructured":"Amit M, Tam S, Boonsripitayanon M, Cabanillas ME, Busaidy NL, Grubbs EG, Lai SY, Gross ND, Sturgis EM, Zafereo ME. Association of lymph node density with survival of patients with papillary thyroid cancer. JAMA Otolaryngol-Head Neck Surg. 2018;144(2):108\u201314.","journal-title":"JAMA Otolaryngol-Head Neck Surg."},{"issue":"6","key":"17290_CR4","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.ejso.2021.01.028","volume":"47","author":"G Zheng","year":"2021","unstructured":"Zheng G, Ma C, Sun H, et al. Safety and surgical outcomes of transoral endoscopic thyroidectomy vestibular approach for papillary thyroid cancer: a two-centre study. Eur J Surg Oncol. 2021;47(6):1346\u201351.","journal-title":"Eur J Surg Oncol."},{"issue":"21","key":"17290_CR5","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1200\/JCO.2014.59.8391","volume":"33","author":"MA Adam","year":"2015","unstructured":"Adam MA, Pura J, Goffredo P, et al. Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer. J Clin Oncol. 2015;33(21):2370\u20135.","journal-title":"J Clin Oncol."},{"issue":"7","key":"17290_CR6","doi-asserted-by":"publisher","first-page":"e2118526","DOI":"10.1001\/jamanetworkopen.2021.18526","volume":"4","author":"S Xu","year":"2021","unstructured":"Xu S, Huang H, Qian J, et al. Prevalence of Hashimoto thyroiditis in adults with papillary thyroid cancer and its association with cancer recurrence and outcomes. JAMA Netw Open. 2021;4(7):e2118526.","journal-title":"JAMA Netw Open."},{"issue":"1","key":"17290_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the american thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid."},{"issue":"6","key":"17290_CR8","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1089\/thy.2018.0128","volume":"29","author":"W Dong","year":"2019","unstructured":"Dong W, Horiuchi K, Tokumitsu H, et al. Time-varying pattern of mortality and recurrence from papillary thyroid cancer: lessons from a long-term follow-up. Thyroid. 2019;29(6):802\u20138.","journal-title":"Thyroid."},{"key":"17290_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ijsu.2016.09.083","volume":"38","author":"S Kuba","year":"2017","unstructured":"Kuba S, Yamanouchi K, Hayashida N, et al. Total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer: comparative analysis after propensity score matching: a multicenter study. Int J Surg. 2017;38:143\u20138.","journal-title":"Int J Surg."},{"issue":"18","key":"17290_CR10","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1200\/JCO.2017.75.0232","volume":"36","author":"RJ Molenaar","year":"2018","unstructured":"Molenaar RJ, Sidana S, Radivoyevitch T, et al. Risk of hematologic malignancies after radioiodine treatment of well-differentiated thyroid cancer. J Clin Oncol. 2018;36(18):1831\u20139.","journal-title":"J Clin Oncol."},{"issue":"13","key":"17290_CR11","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1200\/JCO.21.01841","volume":"40","author":"E Pasqual","year":"2022","unstructured":"Pasqual E, Schonfeld S, Morton LM, et al. Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies. J Clin Oncol. 2022;40(13):1439\u201349. https:\/\/doi.org\/10.1200\/JCO.21.01841.","journal-title":"J Clin Oncol."},{"issue":"6","key":"17290_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1089\/thy.2017.0102","volume":"27","author":"RM Tuttle","year":"2017","unstructured":"Tuttle RM, Haugen B, Perrier ND. Updated American joint committee on cancer\/tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer (eighth edition): What changed and why? Thyroid. 2017;27(6):751\u20136.","journal-title":"Thyroid."},{"key":"17290_CR13","volume-title":"Breakthroughs in Statistics: Methodology and Distribution","year":"1992","unstructured":"Kotz S, Johnson NL, editors. Breakthroughs in Statistics: Methodology and Distribution. New York: Springer New York; 1992."},{"issue":"1","key":"17290_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/SLA.0000000000002693","volume":"268","author":"DA Hashimoto","year":"2018","unstructured":"Hashimoto DA, Rosman G, Rus D, et al. Artificial intelligence in surgery: promises and perils. Ann Surg. 2018;268(1):70\u20136.","journal-title":"Ann Surg."},{"issue":"1","key":"17290_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12874-018-0482-1","volume":"18","author":"JL Katzman","year":"2018","unstructured":"Katzman JL, Shaham U, Cloninger A, et al. DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med Res Methodol. 2018;18(1):24.","journal-title":"BMC Med Res Methodol."},{"key":"17290_CR16","doi-asserted-by":"publisher","first-page":"967758","DOI":"10.3389\/fonc.2022.967758","volume":"12","author":"L Yan","year":"2022","unstructured":"Yan L, Gao N, Ai F, et al. Deep learning models for predicting the survival of patients with chondrosarcoma based on a surveillance, epidemiology, and end results analysis. Front Oncol. 2022;12:967758.","journal-title":"Front Oncol."},{"issue":"6","key":"17290_CR17","doi-asserted-by":"publisher","first-page":"e205842","DOI":"10.1001\/jamanetworkopen.2020.5842","volume":"3","author":"Y She","year":"2020","unstructured":"She Y, Jin Z, Wu J, et al. Development and validation of a deep learning model for non-small cell lung cancer survival. JAMA Netw Open. 2020;3(6):e205842.","journal-title":"JAMA Netw Open."},{"issue":"4","key":"17290_CR18","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1097\/SR9.0000000000000035","volume":"6","author":"G Mathew","year":"2021","unstructured":"Mathew G, Agha R. STROCSS 2021: strengthening the reporting of cohort, cross-sectional and case-control studies in surgery. IJS Short Rep. 2021;6(4):e35.","journal-title":"IJS Short Rep."},{"key":"17290_CR19","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Data, 17 Registries, Nov 2022 Sub (2000-2020) - Linked To County Attributes - Time Dependent (1990-2021) Income\/Rurality, 1969-2021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission."},{"issue":"6","key":"17290_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol."},{"issue":"6","key":"17290_CR21","first-page":"1050","volume":"114","author":"ID Hay","year":"1993","unstructured":"Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114(6):1050.","journal-title":"Surgery."},{"issue":"3","key":"17290_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1089\/thy.2015.0315","volume":"26","author":"IJ Nixon","year":"2016","unstructured":"Nixon IJ, Wang LY, Migliacci JC, et al. An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC\/UICC staging system for well-differentiated thyroid cancer. Thyroid. 2016;26(3):373\u201380.","journal-title":"Thyroid."},{"issue":"36","key":"17290_CR23","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1200\/JCO.2016.68.9372","volume":"34","author":"MA Adam","year":"2016","unstructured":"Adam MA, Thomas S, Hyslop T, et al. Exploring the relationship between patient age and cancer-specific survival in papillary thyroid cancer: rethinking current staging systems. J Clin Oncol. 2016;34(36):4415\u201320.","journal-title":"J Clin Oncol."},{"issue":"6","key":"17290_CR24","doi-asserted-by":"publisher","first-page":"E878","DOI":"10.1210\/jc.2011-2864","volume":"97","author":"J Jonklaas","year":"2012","unstructured":"Jonklaas J, Nogueras-Gonzalez G, Munsell M, et al. The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab. 2012;97(6):E878\u201387.","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"17290_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jamaoto.2022.3781","volume":"149","author":"SS Wu","year":"2023","unstructured":"Wu SS, Joshi N, Sharrett J, et al. Risk factors associated with recurrence and death in patients with tall cell papillary thyroid cancer: a single-institution cohort study with predictive nomogram. JAMA Otolaryngol Head Neck Surg. 2023;149(1):79\u201386.","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"issue":"1","key":"17290_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/thy.2022.0353","volume":"33","author":"A Wilhelm","year":"2023","unstructured":"Wilhelm A, Conroy PC, Calthorpe L, et al. Disease-specific survival trends for patients presenting with differentiated thyroid cancer and distant metastases in the United States, 1992\u20132018. Thyroid. 2023;33(1):63\u201373.","journal-title":"Thyroid."},{"issue":"1","key":"17290_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1210\/jc.2012-2458","volume":"98","author":"FA Verburg","year":"2013","unstructured":"Verburg FA, M\u00e4der U, Tanase K, et al. Life expectancy is reduced in differentiated thyroid cancer patients \u2265 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J Clin Endocrinol Metab. 2013;98(1):172\u201380.","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"17290_CR28","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2011-2512","volume":"97","author":"C Schvartz","year":"2012","unstructured":"Schvartz C, Bonnetain F, Dabakuyo S, et al. Impact on overall survival of radioactive iodine in low-risk differentiated thyroid cancer patients. J Clin Endocrinol Metab. 2012;97(5):1526\u201335.","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"17290_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/thy.2014.0298","volume":"25","author":"W Sacks","year":"2015","unstructured":"Sacks W, Wong RM, Bresee C, et al. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer. Thyroid. 2015;25(4):377\u201385.","journal-title":"Thyroid."},{"issue":"19","key":"17290_CR30","doi-asserted-by":"publisher","first-page":"4439","DOI":"10.1002\/cncr.26070","volume":"117","author":"NG Iyer","year":"2011","unstructured":"Iyer NG, Morris LG, Tuttle RM, et al. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer. 2011;117(19):4439\u201346.","journal-title":"Cancer."},{"issue":"8","key":"17290_CR31","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1089\/thy.2014.0557","volume":"25","author":"GH Seo","year":"2015","unstructured":"Seo GH, Cho YY, Chung JH, et al. Increased risk of leukemia after radioactive iodine therapy in patients with thyroid cancer: a nationwide, population-based study in Korea. Thyroid. 2015;25(8):927\u201334.","journal-title":"Thyroid."},{"issue":"12","key":"17290_CR32","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti S, Durante C, Hartl D, et al. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 2019;30(12):1856\u201383.","journal-title":"Ann Oncol."},{"issue":"4","key":"17290_CR33","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1210\/jc.2014-4332","volume":"100","author":"E Ruel","year":"2015","unstructured":"Ruel E, Thomas S, Dinan M, et al. Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. J Clin Endocrinol Metab. 2015;100(4):1529\u201336.","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"17290_CR34","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/(SICI)1097-0142(19980115)82:2<389::AID-CNCR19>3.0.CO;2-V","volume":"82","author":"RW Tsang","year":"1998","unstructured":"Tsang RW, Brierley JD, Simpson WJ, et al. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Cancer. 1998;82(2):375\u201388.","journal-title":"Cancer."},{"issue":"9","key":"17290_CR35","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1210\/JC.2015-1346","volume":"100","author":"AA Carhill","year":"2015","unstructured":"Carhill AA, Litofsky DR, Ross DS, et al. Long-term outcomes following therapy in differentiated thyroid carcinoma: NTCTCS registry analysis 1987\u20132012. J Clin Endocrinol Metab. 2015;100(9):3270\u20139.","journal-title":"J Clin Endocrinol Metab."},{"issue":"15","key":"17290_CR36","doi-asserted-by":"publisher","first-page":"928","DOI":"10.21037\/atm-18-1301","volume":"8","author":"Y Yao","year":"2020","unstructured":"Yao Y, Cheng S, Xu X, et al. Prognostic factors and the effect of radioiodine on patients with locally advanced differentiated thyroid cancer. Ann Transl Med. 2020;8(15):928.","journal-title":"Ann Transl Med."},{"key":"17290_CR37","doi-asserted-by":"publisher","first-page":"e1260","DOI":"10.1210\/clinem\/dgad580","volume":"109","author":"P Dai","year":"2023","unstructured":"Dai P, Zhao W, Zheng X, et al. Effect of radioactive iodine therapy on cancer-specific survival of papillary thyroid cancer tall cell variant. J Clin Endocrinol Metab. 2023;109:e1260.","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"17290_CR38","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1089\/thy.2017.0203","volume":"27","author":"SB Chinn","year":"2017","unstructured":"Chinn SB, Zafereo ME, Waguespack SG, et al. Long-term outcomes of lateral neck dissection in patients with recurrent or persistent well-differentiated thyroid cancer. Thyroid. 2017;27(10):1291\u20139.","journal-title":"Thyroid."},{"issue":"12","key":"17290_CR39","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1001\/jamasurg.2018.2659","volume":"153","author":"ML Hung","year":"2018","unstructured":"Hung ML, Wu JX, Li N, et al. Association of radioactive iodine administration after reoperation with outcomes among patients with recurrent or persistent papillary thyroid cancer. JAMA Surg. 2018;153(12):1098\u2013104.","journal-title":"JAMA Surg."},{"issue":"1","key":"17290_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1001\/jamasurg.2022.5781","volume":"158","author":"S Xu","year":"2023","unstructured":"Xu S, Huang H, Huang Y, et al. Comparison of lobectomy vs total thyroidectomy for intermediate-risk papillary thyroid carcinoma with lymph node metastasis. JAMA Surg. 2023;158(1):73\u20139.","journal-title":"JAMA Surg."},{"issue":"4","key":"17290_CR41","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/SLA.0000000000000925","volume":"260","author":"MA Adam","year":"2014","unstructured":"Adam MA, Pura J, Gu L, et al. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg. 2014;260(4):601\u20137.","journal-title":"Ann Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17290-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17290-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17290-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T08:57:35Z","timestamp":1748854655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17290-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,20]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["17290"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17290-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,20]]},"assertion":[{"value":"8 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.Z. has research grants to MD Anderson Cancer Center for clinical trials from Merck and Eli Lilly.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}